No Detail Found!

NSAIDs in COVID-19, friend or foe?

Author(s)
Reham Mahrous Department of Anesthesia, surgical ICU and pain management, Cairo University,,Egypt
Amr Abdelnasser Department of Anesthesia, surgical ICU and pain management, Cairo University,,Egypt
Raghda Fouda University of Irvine California, USA; Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Egypt
Mohamed Abd Al Moniem Morsy Department of Anesthesia, surgical ICU and pain management, Cairo University, Egypt
Mohamed Ahmed Ibrahim Department of Anesthesia, surgical ICU and pain management, Cairo University,,Egypt
Omnia Mandour Department of Anesthesia, surgical ICU and pain management, Cairo University,,Egypt
Abstract
At the beginning of COVID-19 pandemic the use of NSAIDS was avoided. This was because the previous studies suggesting that NSAIDs may be linked to an increased risk of lower respiratory tract infection consequences. Later on studies involved the patients who used NSAIDs for some chronic conditions and showed no additional harm among these patients. Then many studied assessed the benefit of using NSAIDs in COVID-19 patients for management of pain and fever and showed no additional risk among these patients.
Publication Details
Page(s) 427-429
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 26, Issue: 4, Year: 2022

Request the full text from PASTIC

Keywords
26(4):427-429, friend or foe? Anaesth. pain intensive care 2022, DOI: 10.35975/apic.v26i4.1942, Citation: Mahrous R, Morsy MAM, Mandour O. NSAIDs in COVID-19, Fouda R, Ibrahim MA, Abdelnasser A
0

Citations

0

Downloads

19

Views